B2 Adrenergic Receptor Polymorphisms and Treatment- Outcomes in Cardiovascular Diseases

B2 Adrenergic Receptor Polymorphisms and Treatment- Outcomes in Cardiovascular Diseases

Cardiovascular diseases (CVD) represent the major health problem in the western world and heavy social and economic burden. Under this name an eterogenous group of multifactorial conditions is included. There is appreciable inter-individual variability in the susceptibility to cardiovascular disease and in the response to the associated pharmacological treatments. Genetic polymorphism may be, at least in part, responsible for both susceptibility to disease and inter-individual variability in response to pharmacological treatments.